搜索临床试验以:拉米夫定
总计533个结果
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)招聘中
-
ViiV HealthcareGlaxoSmithKline; Shionogi完全的感染,人类免疫缺陷病毒 I美国, 西班牙, 德国, 澳大利亚, 加拿大, 比利时, 丹麦, 荷兰, 英国, 法国, 意大利, 罗马尼亚
-
Rigshospitalet, DenmarkUniversity of Copenhagen完全的
-
Menzies School of Health ResearchInternational Centre for Diarrhoeal Disease Research, Bangladesh; Addis Ababa University; Tribhuvan... 和其他合作者完全的
-
Professor Francois Venter完全的
-
University of WashingtonGlaxoSmithKline; Gilead Sciences完全的
-
NovartisNovartis Pharmaceuticals完全的
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp & Dohme LLC; Janssen... 和其他合作者终止
-
Erasmus Medical CenterCatharina Ziekenhuis Eindhoven; Maasstad Hospital, Rotterdam; MC Haaglanden, The Hague; Elisabeth... 和其他合作者招聘中
-
Makerere UniversityMassachusetts General Hospital完全的
-
Hospital Authority, Hong KongThe University of Hong Kong未知
-
Therapeutic Concepts完全的
-
NovartisNovartis Pharmaceuticals完全的
-
NovartisNovartis Pharmaceuticals完全的慢性乙型肝炎美国, 英国, 西班牙, 大韩民国, 火鸡, 泰国
-
University of Texas Southwestern Medical CenterChildren's Medical Center Dallas完全的
-
Societa' Italiana Di Malattie Infettive E Tropicali招聘中
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
National Institute of Allergy and Infectious Diseases...完全的
-
National Institute of Allergy and Infectious Diseases...Agouron Pharmaceuticals; Glaxo Wellcome; Chiron Corporation完全的
-
Glaxo Wellcome完全的
-
University of California, San DiegoNational Institute of Mental Health (NIMH); Peking University; Beijing YouAn Hospital; Beijing Ditan... 和其他合作者完全的
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)完全的
-
Harvard School of Public Health (HSPH)Bristol-Myers Squibb; McGill University Health Centre/Research Institute of the McGill University... 和其他合作者完全的
-
Pedro CahnViiV Healthcare撤销
-
Uijeongbu St. Mary Hospital未知Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
-
Shao-quan Zhang未知
-
GlaxoSmithKline完全的